All Stories

  1. Ultradeformable liposomal delivery of vismodegib modulates its biological activity in melanoma cells
  2. Modular Design of Mitochondrion-Targeted Iron Chelators Allows Highly Selective Antiparasitic Activity against Trypanosomes and Apicomplexan Parasites
  3. Mitochondrial Transfer Rescues Respiration to Support De Novo Pyrimidine Biosynthesis and Tumor Progression
  4. Functional mitochondrial respiration is essential for glioblastoma tumour growth
  5. Effect of substituents at the C3´, C3´N, C10 and C2-meta-benzoate positions of taxane derivatives on their activity against resistant cancer cells
  6. NDRG1 acts as an oncogene in triple-negative breast cancer and its loss sensitizes cells to mitochondrial iron chelation
  7. Third-generation taxanes SB-T-121605 and SB-T-121606 are effective in pancreatic ductal adenocarcinoma
  8. Chelation of Mitochondrial Iron as an Antiparasitic Strategy
  9. Mitochondrially targeted deferasirox kills cancer cellsviasimultaneous iron deprivation and ferroptosis induction
  10. Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial
  11. Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model
  12. Generation and characterization of human U-2 OS cell lines with the CRISPR/Cas9-edited protoporphyrinogen oxidase IX gene
  13. Targeting Mitochondrial Iron Metabolism Suppresses Tumor Growth and Metastasis by Inducing Mitochondrial Dysfunction and Mitophagy
  14. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in Mask Mice
  15. Mitochondrially targeted gentisic acid synergizes with doxycycline in killing breast cancer cells
  16. The role of mitochondria in tamoxifen resistance in breast cancer cells
  17. Effect of stimulated erythropoiesis on SMAD signaling in iron-overloaded and iron-deficient mice
  18. Dihydroorotate Dehydrogenase is critical for tumor initiation of respiration-deficient cancer cells
  19. Liver HFE protein content is posttranscriptionally decreased in iron-deficient mice and rats
  20. Mitochondrial iron chelation as a novel anti-cancer strategy
  21. Estrogen receptor regulation by microRNA
  22. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice
  23. Erythropoietin administration increases splenic erythroferrone protein content and liver TMPRSS6 protein content in rats
  24. Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms
  25. Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells
  26. Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer
  27. Tumor-initiating cells exhibit profound deregulation of iron metabolism
  28. MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma
  29. Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats
  30. Mitochondrially Targeted Vitamin E Succinate Modulates Expression of Mitochondrial DNA Transcripts and Mitochondrial Biogenesis
  31. Cancer cells can take mitochondria from surrounding cells, and it can help them grow
  32. The Effect of Mitochondrially Targeted Anticancer Agents on Mitochondrial (Super)Complexes
  33. MicroRNA-126 Suppresses Mesothelioma Malignancy by Targeting IRS1 and Interfering with the Mitochondrial Function
  34. Indoleamine-2,3-dioxygenase elevated in tumor-initiating cells is suppressed by mitocans
  35. Corrigendum to: “Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy” [Free Radic Biol Med. 50 (2011) 1546–1555]
  36. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy
  37. Classification of mitocans, anti-cancer drugs acting on mitochondria
  38. Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy: A new paradigm for effective cancer therapy
  39. Mitochondrial Targeting of Vitamin E Succinate Enhances Its Pro-apoptotic and Anti-cancer Activity via Mitochondrial Complex II
  40. Hippo/Mst1 Stimulates Transcription of the Proapoptotic Mediator NOXA in a FoxO1-Dependent Manner
  41. EPO-mediated reduction in Hamp expression in vivo corrects iron deficiency anaemia in TMPRSS6 deficiency
  42. Polymorphisms and mutations of human TMPRSS6 in iron deficiency anemia
  43. Suppression of the hepcidin-encoding geneHamppermits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6
  44. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness
  45. The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
  46. The distal location of the iron responsive region of the hepcidin promoter
  47. The role of STAT, AP-1, E-box and TIEG motifs in the regulation of hepcidin by IL-6 and BMP-9: Lessons from human HAMP and murine Hamp1 and Hamp2 gene promoters
  48. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9
  49. In vivo imaging of hepcidin promoter stimulation by iron and inflammation
  50. Stimulation of non-transferrin iron uptake by iron deprivation in K562 cells
  51. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
  52. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells
  53. Iron deprivation induces apoptosis via mitochondrial changes related to Bax translocation
  54. Heat Shock Protein 90 Recognized as an Iron-Binding Protein Associated with the Plasma Membrane of HeLa Cells
  55. Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells